|1.||Zimmermann, Herbert: 1 article (08/2011)|
|2.||Volknandt, Walter: 1 article (08/2011)|
|3.||Barth, Joern: 1 article (08/2011)|
|4.||Jayaraman, Arathi K: 1 article (01/2011)|
|5.||Jayaraman, Sundararajan: 1 article (01/2011)|
|6.||Maret, Wolfgang: 1 article (08/2009)|
|7.||Li, Yuan: 1 article (08/2009)|
|8.||Koh, Jae Young: 1 article (03/2009)|
|9.||Yoon, Young Hee: 1 article (03/2009)|
|10.||Kim, June-Gone: 1 article (03/2009)|
08/01/2011 - "Zn(2+)-binding of SV31 in viable cells was verified following heterologous transfection of pheochromocytoma cells 12 (PC12) with recombinant red fluorescent SV31 (SV31-RFP) and the fluorescent zinc indicator FluoZin-3. "
08/15/2009 - "By employing a fluorescent Zn(2+) probe, FluoZin-3 acetoxymethyl ester, intracellular Zn(2+) concentrations were measured in undifferentiated and in nerve growth factor (NGF)-differentiated rat pheochromocytoma (PC12) cells. "
|2.||Drug Toxicity (Drug Safety)
07/01/2007 - "Interestingly this impaired recovery phase was found to be sensitive to chelation of intracellular Zn2+. Experiments with the Zn2+ sensitive (and Ca2+-insensitive) fluorescent probe FluoZin-3 confirmed the idea that AMPAR activation increases [Zn2+]i, a phenomenon that is potentiated by mild acidosis. "
|2.||Nerve Growth Factor (NGF)